Chest pain secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
There are no established measures for the secondary prevention of [disease name].
Secondary prevention of chest pain depend on the cause for instance, [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. myocarditis secondary prevention include, [https://www.wikidoc.org/index.php/Clinical clinical] evaluation, [https://www.wikidoc.org/index.php/ECG ECG], and [https://www.wikidoc.org/index.php/Echocardiography echocardiography]. [https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan]. secondary prevention of chest pain caused by GERD avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.
==Secondary Prevention==
Secondary prevention of chest pain depend on the cause:
 
* [[Secondary prevention]] of chest pain due to [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating [https://www.wikidoc.org/index.php/Coronary_heart_disease_risk_factors Category I] risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, [https://www.wikidoc.org/index.php/Coronary_heart_disease_secondary_prevention here].
 
*[https://www.wikidoc.org/index.php/Secondary_prevention secondary prevention] of myocarditis include:<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal
| author = [[C. L. Miklozek]], [[E. M. Kingsley]], [[C. S. Crumpaker]], [[J. F. Modlin]], [[H. D. Royal]], [[P. C. Come]], [[R. Mark]] & [[W. H. Abelmann]]
| title = Serial cardiac function tests in myocarditis
| journal = [[Postgraduate medical journal]]
| volume = 62
| issue = 728
| pages = 577–579
| year = 1986
| month = June
| doi = 10.1136/pgmj.62.728.577
| pmid = 3774697
}}</ref>
**[https://www.wikidoc.org/index.php/Clinical Clinical] evaluation
**[https://www.wikidoc.org/index.php/ECG ECG]
**[https://www.wikidoc.org/index.php/Echocardiography Echocardiography]
**[https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan], [https://www.wikidoc.org/index.php/Nuclear nuclear assessment] in [https://www.wikidoc.org/index.php/Patients patients] that [https://www.wikidoc.org/index.php/Echocardiography echocardiography] is undiagnostic
**[https://www.wikidoc.org/index.php/Patients Patients] should undergo [https://www.wikidoc.org/index.php/Cardiac_function_curve cardiac function] assessment at one and six months and yearly after that.
*[[Secondary prevention]] of GERD include the following:<ref name="pmid15654800">{{cite journal| author=DeVault KR, Castell DO, American College of Gastroenterology| title=Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2005 | volume= 100 | issue= 1 | pages= 190-200 | pmid=15654800 | doi=10.1111/j.1572-0241.2005.41217.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15654800  }}</ref>
**Avoiding foods and beverages that worsen symptoms.
**[https://www.wikidoc.org/index.php/Smoking_cessation Smoking cessation]
**[https://www.wikidoc.org/index.php/Weight_loss Weight loss]
**Eating frequent and small meals
**Avoid lying down for 3 hours after a meal.
**Head raising of the bed while sleeping by securing wood blocks under the bedposts not only extra pillows


OR


Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].


==Secondary Prevention==
You can read in greater detail about each of the risk factor modification topic below by clicking on the link for that topic:
There are no established measures for the secondary prevention of [disease name].


OR
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_smoking_cessation Smoking Cessation]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_weight_management Weight Management]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_physical_activity Physical Activity]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_lipid_management Lipid Management]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_blood_pressure_control BP Control]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_diabetes_control Diabetes Control]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_psychological_factors Management of psychological factors]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_alcohal_consumption Alcohal consumption]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_avoidance_of_air_pollution Avoidance of air pollution]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_additional_therapy_to_reduce_risk_of_MI_and_death Additional therapy to reduce risk of MI and death]'''
*'''[https://www.wikidoc.org/index.php/Chronic_stable_angina_treatment_influenza_vaccination Influneza Vaccination]'''


Effective measures for the secondary prevention of [disease name] include:
*
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


==References==
==References==

Revision as of 14:02, 26 February 2021

Chest pain Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chest pain from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Chest Pain in Pregnancy

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chest pain secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chest pain secondary prevention

CDC on Chest pain secondary prevention

Chest pain secondary prevention in the news

Blogs on Chest pain secondary prevention

to Hospitals Treating Chest pain secondary prevention

Risk calculators and risk factors for Chest pain secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

Secondary prevention of chest pain depend on the cause for instance, chronic stable angina, risk factor modification remains an urgent and essential part of secondary prevention strategy. myocarditis secondary prevention include, clinical evaluation, ECG, and echocardiography. CMR, cardiac CT scan. secondary prevention of chest pain caused by GERD avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.

Secondary Prevention

Secondary prevention of chest pain depend on the cause:

  • Secondary prevention of chest pain due to chronic stable angina, risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating Category I risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, here.


You can read in greater detail about each of the risk factor modification topic below by clicking on the link for that topic:

References

  1. Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S. B.; Fu, M.; Helio, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y. M.; Ristic, A.; Schultheiss, H.-P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P. M. (2013). "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases". European Heart Journal. 34 (33): 2636–2648. doi:10.1093/eurheartj/eht210. ISSN 0195-668X.
  2. C. L. Miklozek, E. M. Kingsley, C. S. Crumpaker, J. F. Modlin, H. D. Royal, P. C. Come, R. Mark & W. H. Abelmann (1986). "Serial cardiac function tests in myocarditis". Postgraduate medical journal. 62 (728): 577–579. doi:10.1136/pgmj.62.728.577. PMID 3774697. Unknown parameter |month= ignored (help)
  3. DeVault KR, Castell DO, American College of Gastroenterology (2005). "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease". Am J Gastroenterol. 100 (1): 190–200. doi:10.1111/j.1572-0241.2005.41217.x. PMID 15654800.

Template:WH Template:WS